Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock ...

FOIA requests to the federal government often are signals. They can be an important early warning of bad publicity, litigation to come, or uncertainties to be hedged and gamed out. When the flow of ...

Putting tariffs on Denmark unless it cedes the island of Greenland could hurt access to a few key products, including popular ...

Consumer-driven innovation, evolving dairy habits and target campaigns focused on value, convenience and sustainability are ...

Havas released its latest trend intelligence report Superwomen at the 2025 Consumer Electronics Showcase this week, delving ...

Nvidia CEO flags the next big thing in AI, Anthropic raising funds valuing AI start-up at $60 billion, and more news to start ...

Vancouver-based Aspect Biosystems has raised a $115-million USD ($165 million CAD) Series B round to realize its ambitions of ...

At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish ...

Everything you need to know about using Ozempic, Wegovy, and Mounjaro to shed those extra pounds. We dive into their perks, ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

Popular medications, such as Ozempic, Mounjaro and Wegovy, are known as GLP-1 agonists as they mimic the natural GLP-1s ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.